Showing 1 posts of 1 posts found.
Biogen Idec will acquire the specialist immunology firm Stromedix for around $500 million. Biogen currently focuses on the development of …
Sobi’s olezarsen recommended for EU approval in severe hypertriglyceridaemia
Hot-tub therapy tested as potential treatment for peripheral artery disease
Raimond takes helm at Nuclera
Most advanced breast cancer patients treated in community settings, Phesi study finds
Orforglipron shows weight and glucose advantages over oral semaglutide in indirect comparison